These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

360 related items for PubMed ID: 23195423

  • 1. Characterization and criteria of embryonic stem and induced pluripotent stem cells for a dopamine replacement therapy.
    Cooper O, Parmar M, Isacson O.
    Prog Brain Res; 2012; 200():265-76. PubMed ID: 23195423
    [Abstract] [Full Text] [Related]

  • 2. Dopaminergic differentiation using pluripotent stem cells.
    Momčilović O, Montoya-Sack J, Zeng X.
    J Cell Biochem; 2012 Dec; 113(12):3610-9. PubMed ID: 22807388
    [Abstract] [Full Text] [Related]

  • 3. Docosahexaenoic acid promotes dopaminergic differentiation in induced pluripotent stem cells and inhibits teratoma formation in rats with Parkinson-like pathology.
    Chang YL, Chen SJ, Kao CL, Hung SC, Ding DC, Yu CC, Chen YJ, Ku HH, Lin CP, Lee KH, Chen YC, Wang JJ, Hsu CC, Chen LK, Li HY, Chiou SH.
    Cell Transplant; 2012 Dec; 21(1):313-32. PubMed ID: 21669041
    [Abstract] [Full Text] [Related]

  • 4. Efficient generation of A9 midbrain dopaminergic neurons by lentiviral delivery of LMX1A in human embryonic stem cells and induced pluripotent stem cells.
    Sánchez-Danés A, Consiglio A, Richaud Y, Rodríguez-Pizà I, Dehay B, Edel M, Bové J, Memo M, Vila M, Raya A, Izpisua Belmonte JC.
    Hum Gene Ther; 2012 Jan; 23(1):56-69. PubMed ID: 21877920
    [Abstract] [Full Text] [Related]

  • 5. Derivation of dopaminergic neurons from pluripotent stem cells.
    Studer L.
    Prog Brain Res; 2012 Jan; 200():243-63. PubMed ID: 23195422
    [Abstract] [Full Text] [Related]

  • 6. [Cell replacement therapy for Parkinson's disease using iPS cells].
    Takahashi J.
    Rinsho Shinkeigaku; 2013 Jan; 53(11):1009-12. PubMed ID: 24291862
    [Abstract] [Full Text] [Related]

  • 7. Progress in Dopaminergic Cell Replacement and Regenerative Strategies for Parkinson's Disease.
    Chen W, Huang Q, Ma S, Li M.
    ACS Chem Neurosci; 2019 Feb 20; 10(2):839-851. PubMed ID: 30346716
    [Abstract] [Full Text] [Related]

  • 8. Stem cell therapies for Parkinson's disease: are trials just around the corner?
    Drouin-Ouellet J, Barker RA.
    Regen Med; 2014 Feb 20; 9(5):553-5. PubMed ID: 25372072
    [No Abstract] [Full Text] [Related]

  • 9. Survival, differentiation, and connectivity of ventral mesencephalic dopamine neurons following transplantation.
    Thompson L, Björklund A.
    Prog Brain Res; 2012 Feb 20; 200():61-95. PubMed ID: 23195415
    [Abstract] [Full Text] [Related]

  • 10. Midbrain dopaminergic neurons: a review of the molecular circuitry that regulates their development.
    Hegarty SV, Sullivan AM, O'Keeffe GW.
    Dev Biol; 2013 Jul 15; 379(2):123-38. PubMed ID: 23603197
    [Abstract] [Full Text] [Related]

  • 11. X-linked severe combined immunodeficiency (X-SCID) rats for xeno-transplantation and behavioral evaluation.
    Samata B, Kikuchi T, Miyawaki Y, Morizane A, Mashimo T, Nakagawa M, Okita K, Takahashi J.
    J Neurosci Methods; 2015 Mar 30; 243():68-77. PubMed ID: 25662444
    [Abstract] [Full Text] [Related]

  • 12. Lmx1b can promote the differentiation of embryonic stem cells to dopaminergic neurons associated with Parkinson's disease.
    Tian LP, Zhang S, Zhang YJ, Ding JQ, Chen SD.
    Biotechnol Lett; 2012 Jul 30; 34(7):1167-74. PubMed ID: 22426839
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Differentiation and Characterization of Dopaminergic Neurons From Baboon Induced Pluripotent Stem Cells.
    Grow DA, Simmons DV, Gomez JA, Wanat MJ, McCarrey JR, Paladini CA, Navara CS.
    Stem Cells Transl Med; 2016 Sep 30; 5(9):1133-44. PubMed ID: 27343168
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Clinical translation of stem cell transplantation in Parkinson's disease.
    Lindvall O.
    J Intern Med; 2016 Jan 30; 279(1):30-40. PubMed ID: 26332959
    [Abstract] [Full Text] [Related]

  • 17. Induced dopaminergic neurons: A new promise for Parkinson's disease.
    Xu Z, Chu X, Jiang H, Schilling H, Chen S, Feng J.
    Redox Biol; 2017 Apr 30; 11():606-612. PubMed ID: 28110217
    [Abstract] [Full Text] [Related]

  • 18. Cell therapy for Parkinson's disease: Functional role of the host immune response on survival and differentiation of dopaminergic neuroblasts.
    Wenker SD, Leal MC, Farías MI, Zeng X, Pitossi FJ.
    Brain Res; 2016 May 01; 1638(Pt A):15-29. PubMed ID: 26239914
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.